Olanzapine versus haloperidol in the treatment of first episode psychosis

被引：3
|
作者：
Sanger, TM [1 ]
Lieberman, JA [1 ]
Tohen, M [1 ]
Tollefson, GD [1 ]
机构：
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
SCHIZOPHRENIA RESEARCH | 1998年 / 29卷 / 1-2期
关键词：
D O I：
10.1016/S0920-9964(97)88685-9
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：151 / 151
页数：1
相关论文
共 50 条
  • [21] Neurocognitive effects of olanzapine and low-dose haloperidol: A two-year treatment study in first episode psychosis
    Keefe, RSE
    Seidman, LJ
    Christensen, BK
    Hamer, RM
    Yurgelun-Todd, DA
    Lewine, RRJ
    Sitskoorn, MM
    Sharma, T
    Tohen, M
    Lieberman, JA
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 26S - 26S
  • [22] Neurocognitive effects of olanzapine and low-dose haloperidol: A two-year treatment study in first episode psychosis
    Keefe, RSE
    Seidman, LJ
    Christensen, B
    Hamer, RM
    Yurgelun-Todd, D
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 206 - 206
  • [23] Treatment response to olanzapine and haloperidol and its association with dopamine D2 receptor occupancy in first-episode psychosis
    Zipursky, RB
    Christensen, BK
    Daskalakis, Z
    Epstein, I
    Roy, P
    Furimsky, I
    Sanger, T
    Kapur, S
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2005, 50 (08): : 462 - 469
  • [24] First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol
    Green, AI
    Tohen, MF
    Hamer, RM
    Strakowski, SM
    Lieberman, JA
    Glick, I
    Clark, WS
    SCHIZOPHRENIA RESEARCH, 2004, 66 (2-3) : 125 - 135
  • [25] Comorbid substance use disorder and first episode schizophrenia: Acute effects of olanzapine versus haloperidol
    Green, A
    Tohen, M
    Strakowski, SM
    Lieberman, JA
    Glick, ID
    Clarke, SW
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 230 - 230
  • [26] Treatment responsiveness with olanzapine in first-episode psychosis after zero dup
    Woods, SW
    Miller, TJ
    Zipursky, RB
    Perkins, DO
    Addington, J
    Tohen, M
    Breier, A
    McGlashan, T
    SCHIZOPHRENIA RESEARCH, 2004, 70 (01) : 80 - 80
  • [27] Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode
    Strakowski, SM
    Johnson, JL
    DelBello, MP
    Hamer, RM
    Green, AI
    Tohen, M
    Lieberman, JA
    Glick, I
    Patel, JK
    SCHIZOPHRENIA RESEARCH, 2005, 78 (2-3) : 161 - 169
  • [28] Optimal haloperidol dosage in first-episode psychosis
    Zhang-Wong, J
    Zipursky, RB
    Beiser, M
    Bean, G
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1999, 44 (02): : 164 - 167
  • [29] First episode psychosis and substance abuse: A two-year efficacy trial of olanzapine vs. haloperidol
    Green, Alan I.
    Hamer, Robert M.
    Woolson, Sandra L.
    Tohen, Mauricio
    Lieberman, Jeffrey A.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S112 - S112
  • [30] Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis
    Keefe, RSE
    Seidman, LJ
    Christensen, BK
    Hamer, RM
    Sharma, T
    Sitskoorn, MM
    Rock, SL
    Woolson, S
    Tohen, M
    Tollefson, GD
    Sanger, TM
    Lieberman, JA
    BIOLOGICAL PSYCHIATRY, 2006, 59 (02) : 97 - 105
12345